SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 34 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $657 | -99.9% | 741,995 | +69.5% | 0.00% | – |
| Q3 2022 | $687,000 | +38.5% | 437,805 | +77.5% | 0.00% | – |
| Q2 2022 | $496,000 | -19.9% | 246,659 | +85.3% | 0.00% | – |
| Q4 2021 | $619,000 | -62.7% | 133,148 | -22.3% | 0.00% | -100.0% |
| Q2 2021 | $1,660,000 | -48.5% | 171,293 | -56.0% | 0.00% | -50.0% |
| Q1 2021 | $3,221,000 | +2938.7% | 389,462 | +2412.3% | 0.00% | – |
| Q4 2020 | $106,000 | -98.4% | 15,502 | -97.4% | 0.00% | -100.0% |
| Q3 2020 | $6,564,000 | +1152.7% | 588,676 | +605.7% | 0.01% | +700.0% |
| Q2 2020 | $524,000 | +219.5% | 83,412 | -6.4% | 0.00% | – |
| Q1 2020 | $164,000 | +102.5% | 89,093 | +132.5% | 0.00% | – |
| Q3 2019 | $81,000 | -79.6% | 38,313 | -74.3% | 0.00% | -100.0% |
| Q2 2019 | $398,000 | -19.6% | 149,209 | +43.2% | 0.00% | 0.0% |
| Q1 2019 | $495,000 | +482.4% | 104,217 | +438.1% | 0.00% | – |
| Q3 2018 | $85,000 | -95.5% | 19,367 | -92.7% | 0.00% | -100.0% |
| Q2 2018 | $1,905,000 | -74.2% | 264,608 | -81.6% | 0.00% | -80.0% |
| Q1 2018 | $7,389,000 | +54.8% | 1,434,670 | +14.2% | 0.01% | +42.9% |
| Q4 2017 | $4,773,000 | +407.8% | 1,256,154 | +127.3% | 0.01% | +600.0% |
| Q3 2017 | $940,000 | -32.3% | 552,649 | -20.4% | 0.00% | -50.0% |
| Q2 2017 | $1,388,000 | +168.5% | 694,101 | +430.1% | 0.00% | +100.0% |
| Q1 2017 | $517,000 | -57.6% | 130,937 | -47.3% | 0.00% | -66.7% |
| Q4 2016 | $1,219,000 | +2001.7% | 248,685 | +2291.2% | 0.00% | – |
| Q2 2016 | $58,000 | -85.8% | 10,400 | -86.3% | 0.00% | -100.0% |
| Q1 2016 | $408,000 | -87.7% | 75,889 | -80.1% | 0.00% | -85.7% |
| Q4 2015 | $3,315,000 | +573.8% | 380,612 | +549.2% | 0.01% | +600.0% |
| Q3 2015 | $492,000 | -79.0% | 58,627 | -56.0% | 0.00% | -75.0% |
| Q2 2015 | $2,348,000 | -57.0% | 133,270 | -71.8% | 0.00% | -60.0% |
| Q1 2015 | $5,464,000 | +1771.2% | 472,684 | +1532.1% | 0.01% | +900.0% |
| Q4 2014 | $292,000 | – | 28,961 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,623,533 | $22,851,000 | 6.45% |
| Avoro Capital Advisors LLC | 1,146,579 | $9,987,000 | 3.44% |
| Cormorant Asset Management, LP | 2,095,334 | $18,250,000 | 2.18% |
| Healthcare Value Capital, LLC | 50,000 | $436,000 | 0.72% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $174,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 300,000 | $2,613,000 | 0.14% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 20,398 | $177,000 | 0.10% |
| Granite Investment Partners, LLC | 89,622 | $781,000 | 0.07% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 54,634 | $476,000 | 0.06% |
| Trexquant Investment LP | 67,929 | $592,000 | 0.05% |